SCHEMBL18034508

SCHEMBL18034508

CC(CO)C1OC(=O)C=C2C1CC1OC(=O)[C@]3(C)C1[C@]2(C)CC[C@@H]3O

nearest known ligand 0.33

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 1/20 0.33
▸ POLB P06746 1/20 0.33
▸ HTT P42858 1/20 0.33
▸ SMN1; SMN2 Q16637 1/20 0.33
▸ STAT3 P40763 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18034519 0.85 JUN (0.40) STAT3
SCHEMBL18034507 0.70 JUN (0.33) LMNAHTTSMN1; SMN2
Nagilactone E SCHEMBL30496589 0.61 JUN (0.65) LMNAPOLBHTTSMN1; SMN2STAT3
SCHEMBL18034496 0.57 LMNA (0.69) LMNAPOLBHTTSMN1; SMN2
SCHEMBL29709891 0.56 JUN (0.52) STAT3
SCHEMBL29709940 0.54 JUN (0.78) STAT3
SCHEMBL15856565 0.52 MAPT (0.34) POLBHTT
SCHEMBL18026197 0.50 HIF1A (0.65) LMNA
SCHEMBL15507620 0.49 PTPN1 (0.34) LMNA
SCHEMBL15726644 0.48 KDM4E (0.37) POLBHTTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2016131426-A1 NAGILACTONE COMPOUNDS HAVING ANTILIPEMIC ACTIVITY, PREPARATION METHOD THEREFOR AND USES THEREOF 中国科学院上海药物研究所 2016-08-25 — — WO disclosed
Send feedback